supply of atropine sulphate 0.6mg per ml 1ml inj (dp2026-2027) bupivacaine hcl 0.5 percent hyperbaric for spinal 4ml inj (dp2026-2027) bupivacaine hcl 0.5 percent solution for inj (dp2026-2027) buprenorphine hcl 0.3mg per ml inj (dp2026-2027) dexmedotimidine 100mcg per ml inj (dp2026-2027) lignocaine hcl 2 percent inj 30ml vial (dp2026-2027)atropine sulphate 0.6mg per ml 1ml inj (dp2026-2027) bupivacaine hcl 0.5 percent hyperbaric for spinal 4ml inj (dp2026-2027) bupivacaine hcl 0.5 percent solution for inj (dp2026-2027) buprenorphine hcl 0.3mg per ml inj (dp2026-2027) dexmedotimidine 100mcg per ml inj (dp2026-2027) lignocaine hcl 2 percent inj 30ml vial (dp2026-2027),atropine sulphate 0.6mg per ml 1ml inj (dp2026-2027) [ warranty period: 30 months after the date of delivery ] ] , bupivacaine hcl 0.5 percent hyperbaric for spinal 4ml inj (dp2026-2027) [ warranty p eriod: 30 months after the date of delivery ] ] , bupivacaine hcl 0.5 percent solution for inj (dp2026-2027) [ warranty period: 30 mon ths after the date of delivery ] ] , buprenorphine hcl 0.3mg per ml inj (dp2026-2027) [ warranty period: 30 months afte r the date of delivery ] ] , dexmedotimidine 100mcg per ml inj (dp2026-2027) [ warranty period: 30 months aft er the date of delivery ] ] , lignocaine hcl 2 percent inj 30ml vial (dp2026-2027) [ warranty period: 30 months af ter the date of delivery ] ] => limited